angiotensin ii has been researched along with omapatrilat in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azizi, M; Guyene, TT; Mangold, B; Massien, C; Ménard, J; Vesterqvist, O | 1 |
| Weber, M | 1 |
| Block, AJ; Isaac, D; Kerut, EK; Pfeffer, MA; Porter, CB; Proulx, G; Qian, C; Rouleau, JL; Sestier, F; Stewart, DJ | 1 |
| Espiner, EA; Frampton, CM; Nicholls, MG; Powell, JD; Rademaker, MT; Richards, AM; Troughton, RW; Yandle, TG | 1 |
| Averill, DB; Brosnihan, KB; Chappell, MC; Dean, RH; Diz, DI; Ferrario, CM; Iskandar, SS | 1 |
| Maniu, CV; Meyer, DM; Redfield, MM | 1 |
| Chaitman, BR; Friedman, JB; Ivleva, AY; Lawrence, JH; Lenis, JH; Pangerl, AM; Reisin, LH; Stieber, DM; Toth, C; Ujda, M | 1 |
| Dendorfer, A; Dominiak, P; Raasch, W | 1 |
| Basso, N; Cini, R; Inserra, F; Paglia, N; Terragno, NA | 1 |
| Angus, PW; Brown, L; Burrell, LM; Casley, D; Herath, CB; Jia, Z; Lubel, JS; Tikellis, C; Velkoska, E | 1 |
| Gao, YJ; Lee, RM; Lu, C; Su, LY | 1 |
| Idikio, H; Jugdutt, BI; Jugdutt, C; Menon, V; Palaniyappan, A; Uwiera, RR | 1 |
2 review(s) available for angiotensin ii and omapatrilat
| Article | Year |
|---|---|
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Pressure; Heart Failure; Humans; Hypertension; Pyridines; Renin; Survival Rate; Thiazepines; Treatment Outcome; Vasodilation | 1999 |
Effect of omapatrilat on the aging process of the normal rat.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Atrial Natriuretic Factor; Cardiovascular System; Cognition; Inflammation; Kidney; Nitric Oxide Synthase; Protease Inhibitors; Pyridines; Rats; Renin-Angiotensin System; Thiazepines; Vasoconstriction; Vasodilation | 2005 |
3 trial(s) available for angiotensin ii and omapatrilat
| Article | Year |
|---|---|
Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fosinopril; Humans; Male; Neprilysin; Pyridines; Reference Values; Renin; Thiazepines; Time Factors | 1999 |
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Double-Blind Method; Endothelin-1; Exercise Tolerance; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Neprilysin; Norepinephrine; Prospective Studies; Pyridines; Radionuclide Ventriculography; Severity of Illness Index; Survival Rate; Thiazepines; Treatment Outcome | 2000 |
Antianginal efficacy of omapatrilat in patients with chronic angina pectoris.
Topics: Angina Pectoris; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Humans; Male; Middle Aged; Neprilysin; Pyridines; Thiazepines | 2005 |
7 other study(ies) available for angiotensin ii and omapatrilat
| Article | Year |
|---|---|
Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiovascular Agents; Cross-Over Studies; Cyclic GMP; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Injections, Intravenous; Kidney; Natriuretic Peptide, Brain; Pyridines; Renin; Sheep; Sodium; Thiazepines | 2000 |
Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Male; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Thiazepines | 2002 |
Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension.
Topics: Adrenomedullin; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Dogs; Fosinopril; Hemodynamics; Hypertension; Kinetics; Male; Neprilysin; Peptides; Protease Inhibitors; Pyridines; Thiazepines; Vasoconstrictor Agents | 2002 |
Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Indans; Male; Neprilysin; Norepinephrine; Peptidyl-Dipeptidase A; Propionates; Protease Inhibitors; Pyridines; Ramipril; Rats; Rats, Inbred SHR; Thiazepines | 2005 |
Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Common Bile Duct; Gene Expression Regulation, Enzymologic; Imidazoles; Leucine; Ligation; Lisinopril; Liver; Liver Cirrhosis, Experimental; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Portal Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Severity of Illness Index; Thiazepines; Time Factors; Vascular Resistance | 2009 |
Endothelium-dependent relaxation factor released by perivascular adipose tissue.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium-Dependent Relaxing Factors; Immunohistochemistry; Male; Peptide Fragments; Potassium Channels; Pyridines; Rats; Rats, Wistar; Thiazepines | 2009 |
Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Collagen; Male; Myocardial Infarction; Myocardial Reperfusion; Osteonectin; Pyridines; Rats, Sprague-Dawley; Secretory Leukocyte Peptidase Inhibitor; Tetrazoles; Thiazepines; Ventricular Remodeling | 2013 |